Objectives: To summarize new knowledge surrounding the physiological activi
ty of tocotrienol, a natural analogue of tocopherol.
Results: The biological activity of vitamin E has generally been associated
with its well-defined antioxidant property, specifically against lipid per
oxidation in biological membranes. In the vitamin E group, a-tocopherol is
considered to be the most active form. However, recent research has suggest
ed tocotrienol to be a better antioxidant. Moreover, tocotrienol has been s
hown to possess novel hypocholesterolemic effects together with an ability
to reduce the atherogenic apolipoprotein B and lipoprotein(a) plasma levels
. In addition, tocotrienol has been suggested to have an anti-thrombotic an
d anti-tumor effect indicating that tocotrienol may serve as an effective a
gent in the prevention and/or treatment of cardiovascular disease and cance
r.
Conclusion: The physiological activities of tocotrienol suggest ii to be su
perior than a-tocopherol in many situations. Hence, the role of tocotrienol
in the prevention of cardiovascular disease and cancer may have significan
t clinical implications. Additional studies on its mechanism of action, as
well as, long-term intervention studies, are needed to clarify its function
. From the pharmacological point-of view, the current formulation of vitami
n E supplements, which is comprised mainly of alpha-tocopherol, may be ques
tionable. Copyright (C) 1999 The Canadian Society of Clinical Chemists.